Maureen R Hewitt, MD
Penn Medicine Clinician of Medicine
Department: Medicine
Contact information
Penn Hematology/Oncology
Suite 201
440 East Marshall Street
West Chester, PA 19380
Suite 201
440 East Marshall Street
West Chester, PA 19380
Office: 610-738-2500
Fax: 610-738-2540
Fax: 610-738-2540
Education:
BS (Finance and Accounting)
Drexel University, 1991.
MD
Louisiana State University Health Sciences Center, 2001.
Permanent linkBS (Finance and Accounting)
Drexel University, 1991.
MD
Louisiana State University Health Sciences Center, 2001.
Selected Publications
Traynor AM, Hewitt M, Liu G, Flaherty KT, Clark J, Freedman SJ, Leighton AM, Watson PA, Zhao B, O'Dwyer PJ, Wilding G.: Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced tumors. Cancer Chemother Pharmacol April 2010.Hewitt MR, Sun W.: Oxaliplatin-Associated Hypersensitivity Reactions: Clinical Presentation and Management. Clinical Colorectal Cancer 2(6): 114-117, 2006.
Hewitt M, Sun W, Haller DG, Mykulowycz K, Tuite C, Rosen M, Caparro M, Giantonio B, Oltoff K.: A phase II trial of the Combination of Capecitabine, Oxaliplatin with Bevacuzynab in the Treatment of Advanced Hepatocellular Carcinoma Preliminary Safety Analysis. Proceedings of the American Society of Clinical Oncology 2006 Notes: Poster Presentation.
Hewitt MR, Haller DG.: Adjuvant Therapy for Colon Cancer, Yesterday, Today and Tomorrow. The Article Reviewed Oncology (Williston Park) 20: 473-475, 2006.
Hewitt MR, Yu K.: Treatment Update for Metastatic Pancreatic Cancer. Community Oncology 3: 28-430, 2006.
Hewitt M, Porter DL, Hummel K, McAlee A, Phillips J, Stadtmauer E, Schuster S, Luger S, Nasta S, Tsai D, Loren A, Perl A, Emerson S, Goldstein SC.: Myeloablative vs. Non-Myeloablative Conditioning with Allogeneic Stem Cell Transplantation for High Risk Non-Hodgkin's Lymphoma. Similar Outcomes Despite Differences in Disease Risk. Proceedings of the American Society of Bone Marrow Transplantation February 2005 Notes: poster presentation.
DeCoster MA, Hewitt MR, Lambeau M, Lascunski M, Bazan NG, : Modulation of Neuronal Sensitivity to Glutamate by Secretory Phospholipases A2 (SPLA2s). Proceedings of the Society for Neuroscience 1997 Notes: poster presentation